SCHEMBL10140987

SCHEMBL10140987

C/C=C(\C=N)c1ccc2cc(I)ccc2c1

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 2/20 0.32
▸ F2 P00734 1/20 0.32
▸ PLG P00747 1/20 0.32
▸ KLKB1 P03952 1/20 0.32
▸ KLK1 P06870 1/20 0.32
▸ PRSS1 P07477 1/20 0.32
▸ F12 P00748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14886275 0.83 PLAU (0.33) PLAU
SCHEMBL12463305 0.80 PLAU (0.32) PLAUF2PLGKLKB1KLK1
SCHEMBL23260542 0.80 F12 (0.52) F12
SCHEMBL23260538 0.77 KDM4E (0.54) PLAU
SCHEMBL12824538 0.76 UGT2B7 (0.41) PLAUF2PLGKLKB1KLK1
SCHEMBL23260537 0.71 CYP1A2 (0.49) —
SCHEMBL23230300 0.69 NPC1 (0.34) PLAUF2PLGKLKB1KLK1
SCHEMBL15958960 0.69 CYP2A6 (0.55) —
SCHEMBL13816639 0.69 — —
SCHEMBL13750252 0.69 ALDH1A1 (0.35) PLAUF2PLGKLKB1KLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012021704-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2012-02-16 — — WO disclosed
WO-2011091417-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2011-07-28 — — WO disclosed
WO-2011081918-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-07-07 — — WO disclosed
WO-2011031904-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-03-17 — — WO disclosed
WO-2011031934-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2011-03-17 — — WO disclosed
Send feedback